William D Rowe

US Patent:

6812339, Nov 2, 2004

Filed:

Sep 10, 2001

Appl. No.:

09/949016

Inventors:

J. Craig Venter - Rockville MD
Jinghui N. Zhang - Rockville MD
Xiangjun Liu - Olney MD
William Rowe - Rockville MD
Anibal Cravchik - Gaithersburg MD
Francis Kalush - Rockville MD
Ashwinikumar Naik - Gaithersburg MD
Gangadharan Subramanian - Columbia MD
Trevor Woodage - Washington DC

Assignee:

Applera Corporation - Norwalk CT

International Classification:

C07H 2104

US Classification:

536 2431, 536 243, 536 231, 435 6, 435 912

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to human disease. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant human disease associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

6825336, Nov 30, 2004

Filed:

Sep 10, 2001

Appl. No.:

09/949001

Inventors:

J. Craig Venter - Rockville MD
Jinghui N. Zhang - Rockville MD
Xiangjun Liu - Olney MD
William Rowe - Rockville MD
Anibal Cravchik - Gaithersburg MD
Francis Kalush - Rockville MD
Ashwinikumar Naik - Gaithersburg MD
Gangadharan Subramanian - Columbia MD
Trevor Woodage - Washington DC

Assignee:

Applera Corporation - Norwalk CT

International Classification:

C07H 2104

US Classification:

536 2431, 536 233, 536 2433, 536 231

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to osteoporosis. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant osteoporosis associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

6900016, May 31, 2005

Filed:

Sep 10, 2001

Appl. No.:

09/949002

Inventors:

J. Craig Venter - Rockville MD, US
Jinghui N. Zhang - Rockville MD, US
Xiangjun Liu - Olney MD, US
William Rowe - Rockville MD, US
Anibal Cravchik - Gaithersburg MD, US
Francis Kalush - Rockville MD, US
Ashwinikumar Naik - Gaithersburg MD, US
Gangadharan Subramanian - Columbia MD, US
Trevor Woodage - Washington DC, US

Assignee:

Applera Corporation - Norwalk CT

International Classification:

C12Q001/68
C12P019/34
C07K013/00
C07H021/04

US Classification:

435 6, 435 912, 4353201, 530350, 536 234

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to inflammatory and autoimmune disorders. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant inflammatory and autoimmune disorders associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

20020144284, Oct 3, 2002

Filed:

Dec 26, 2000

Appl. No.:

09/748427

Inventors:

Robert Burroughs - Doylestown PA, US
William Rowe - Middletown NJ, US

International Classification:

H04N007/173

US Classification:

725/111000, 725/112000

Abstract:

Cable modems and CMTS modules, connected to a single cable so as to provide cable modem service to a respective set of the cable modems, are arranged so one of the CMTSs can backup the other. Each of the CMTSs simultaneously broadcasts its downstream channel on its own assigned one of the cable channels that is accessible by the cable modems for which it is assigned to provide the primary downstream channel, and each cable modem is assigned in addition to its primary downstream channel at least one alternative downstream channel which is supplied by a CMTS other than its primary CMTS, so that when the primary downstream channel of a cable modem becomes invalid the cable modem switches to the alternative downstream channel. When doing so, the cable modem employs many of the parameters that were established during the initialization it performed with the primary CMTS.

US Patent:

20050147987, Jul 7, 2005

Filed:

Jul 19, 2004

Appl. No.:

10/893315

Inventors:

J. Venter - Rockville MD, US
Jinghui Zhang - Rockville MD, US
Xiangjun Liu - Olney MD, US
William Rowe - Rockville MD, US
Anibal Cravchik - Gaithersburg MD, US
Francis Kalush - Rockville MD, US
Ashwinikumar Naik - Gaithersburg MD, US
Gangadharan Subramanian - Columbia MD, US
Trevor Woodage - Washington DC, US

Assignee:

APPLERA CORPORATION (NY) - Norwalk CT

International Classification:

C12Q001/68
C07H021/04

US Classification:

435006000, 536024300

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to type II diabetes and obesity. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant type II diabetes and obesity associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

20070037162, Feb 15, 2007

Filed:

Jul 19, 2004

Appl. No.:

10/893319

Inventors:

J. Venter - Rockville MD, US
Jinghui Zhang - Rockville MD, US
Xiangjun Liu - Olney MD, US
William Rowe - Rockville MD, US
Anibal Cravchik - Gaithersburg MD, US
Francis Kalush - Rockville MD, US
Ashwinikumar Naik - Gaithersburg MD, US
Gangadharan Subramanian - Columbia MD, US
Trevor Woodage - Washington DC, US

Assignee:

APPLERA CORPORATION - Norwalk CT

International Classification:

C12Q 1/68
C07H 21/04

US Classification:

435006000, 536024300

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to osteoporosis. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant osteoporosis associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

20070037165, Feb 15, 2007

Filed:

Sep 15, 2004

Appl. No.:

10/940774

Inventors:

J. Venter - Rockville MD, US
Jinghui Zhang - Rockville MD, US
Xiangjun Liu - Olney MD, US
William Rowe - Rockville MD, US
Anibal Cravchik - Gaithersburg MD, US
Francis Kalush - Rockville MD, US
Ashwinikumar Naik - Gaithersburg MD, US
Gangadharan Subramanian - Columbia MD, US
Trevor Woodage - Washington DC, US

Assignee:

APPLERA CORPORATION - Norwalk CT

International Classification:

C12Q 1/68
C07H 21/04

US Classification:

435006000, 536024300

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to human disease. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant human disease associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.

US Patent:

20070037168, Feb 15, 2007

Filed:

Jan 12, 2005

Appl. No.:

11/033545

Inventors:

J. Venter - Rockville MD, US
Jinghui Zhang - Rockville MD, US
Xiangjun Liu - Olney MD, US
William Rowe - Rockville MD, US
Anibal Cravchik - Gaithersburg MD, US
Francis Kalush - Rockville MD, US
Ashwinikumar Naik - Gaithersburg MD, US
Gangadharan Subramanian - Columbia MD, US
Trevor Woodage - Washington DC, US

Assignee:

APPLERA CORPORATION - Norwalk CT

International Classification:

C12Q 1/68
C07H 21/04

US Classification:

435006000, 536024300

Abstract:

The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to inflammatory and autoimmune disorders. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant inflammatory and autoimmune disorders associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.